» Articles » PMID: 26432865

High-mobility Group Box 1 Promotes Extracellular Matrix Synthesis and Wound Repair in Human Bronchial Epithelial Cells

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

High mobility group box 1 (HMGB1) is a damage-associated molecular pattern (DAMP) protein that binds Toll-like receptors (e.g., TLR4) and the receptor for advanced glycated end products (RAGE). The direct effects of HMGB1 on airway structural cells are not fully known. As epithelial cell responses are fundamental drivers of asthma, including abnormal repair-restitution linked to changes in extracellular matrix (ECM) synthesis, we tested the hypothesis that HMGB1 promotes bronchial epithelial cell wound repair via TLR4 and/or RAGE signaling that regulates ECM (fibronectin and the γ2-chain of laminin-5) and integrin protein abundance. To assess impact of HMGB1 we used molecular and pharmacological inhibitors of RAGE or TLR4 signaling in scratch wound, immunofluorescence, and immunoblotting assays to assess wound repair, ECM synthesis, and phosphorylation of intracellular signaling. HMGB1 increased wound closure, and this effect was attenuated by blocking RAGE and TLR4 signaling. HMGB1-induced fibronectin and laminin-5 (γ2 chain) was diminished by blocking RAGE and/or blunting TLR4 signaling. Similarly, induction of α3-integrin receptor for fibronectin and laminin-5 was also diminished by blocking TLR4 signaling and RAGE. Lastly, rapid and/or sustained phosphorylation of SMAD2, ERK1/2, and JNK signaling modulated HMGB1-induced wound closure. Our findings suggest a role for HMGB1 in human airway epithelial cell repair and restitution via multiple pathways mediated by TLR4 and RAGE that underpin increased ECM synthesis and modulation of cell-matrix adhesion.

Citing Articles

Targeting high-mobility-group-box-1-mediated inflammation: a promising therapeutic approach for myocardial infarction.

Date S, Bhatt L Inflammopharmacology. 2024; 33(2):767-784.

PMID: 39487941 DOI: 10.1007/s10787-024-01586-w.


Etanercept ameliorates psoriasis progression through regulating high mobility group box 1 pathway.

Li S, Li G, Li X, Wu F, Li L Skin Res Technol. 2023; 29(4):e13329.

PMID: 37113086 PMC: 10234177. DOI: 10.1111/srt.13329.


HMGB1, angel or devil, in ischemic stroke.

Gao B, Wang S, Li J, Han N, Ge H, Zhang G Brain Behav. 2023; 13(5):e2987.

PMID: 37062906 PMC: 10176004. DOI: 10.1002/brb3.2987.


TSLP and HMGB1: Inflammatory Targets and Potential Biomarkers for Precision Medicine in Asthma and COPD.

Furci F, Murdaca G, Pelaia C, Imbalzano E, Pelaia G, Caminati M Biomedicines. 2023; 11(2).

PMID: 36830972 PMC: 9953666. DOI: 10.3390/biomedicines11020437.


Progress in Research on TLR4-Mediated Inflammatory Response Mechanisms in Brain Injury after Subarachnoid Hemorrhage.

Wang L, Geng G, Zhu T, Chen W, Li X, Gu J Cells. 2022; 11(23).

PMID: 36497041 PMC: 9740134. DOI: 10.3390/cells11233781.